Isolation of circulating tumor cells from glioblastoma patients by direct immunomagnetic targeting
David A. Lynch(McMaster University), Therese, Paul de Souza(St. George Hospital), Eng‐Siew Koh(Liverpool Hospital), Joseph W. Po(Camden and Campbelltown Hospitals), Matthias Jaeger(UNSW Sydney), Adam G. Cooper, Tara L. Roberts(Camden and Campbelltown Hospitals), Renata Bazina(Liverpool Hospital), James van Gelder(Liverpool Hospital), Mark A. Sheridan(Texas Tech University), Balsam Darwish(Liverpool Hospital), Celine Garrett(Ingham Institute), Simon McKechnie(Liverpool Hospital), Branka Powter(Ingham Institute)
Cited by 0
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
|The Lancet Oncology|2015|1.4k
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k